BCG Vaccine Market by Demographics [Pediatrics (0-18 Years) and Adults (19-35 Years)] - Global Opportunity Analysis and Industry Forecast, 2017-2023

Get 20% Free Customization In This Report

Pharmaceuticals	LI_174419	Pages: 150	Sep 2017 \| 1787 Views
Author's : Amrita Srivastava and Pallavi Jaiswal	Tables: 28	Charts: 10	Formats*:

BCG Vaccine Market Overview:

Global BCG Vaccine Market was valued at $20,366 thousands in 2016, and is estimated to reach $28,051 thousands by 2023, growing at a CAGR of 4.6% from 2017 to 2023. Bacillus Calmette-Gurin (BCG) vaccine is the only vaccine currently available for prevention of tuberculosis (TB). In countries with high prevalence of tuberculosis, one dose is recommended for healthy babies close to the time of birth. However, in areas where tuberculosis is uncommon, only children at high risk are typically immunized, while suspected cases of tuberculosis are individually tested and treated. Adults not infected with tuberculosis and who have not been previously immunized but are frequently exposed to drug-resistant tuberculosis may be immunized as well.

The factors that drive the global BCG vaccine market include increase in prevalence of tuberculosis, especially in developing and underdeveloped countries, and technological advancement in the field of vaccine research. Moreover, the increase in government initiatives and focus on immunization programs globally further boost the market growth. However, side effects of BCG vaccine and a global shortage of this vaccine restricts this growth. Untapped market opportunities in developing regions are expected to provide numerous prospects for market development.

BCG Vaccine Market Segmentation

Get more information on this report : Request Sample Pages

Segment Review

The pediatrics segment held a major share of the BCG vaccine market in 2016, and is expected to maintain its dominance throughout the forecast period. BCG is generally administered to all the infants up to one year of age in countries where BCG vaccination is a part of the national childhood immunization program. In addition, this vaccine can also be given to older children (more than 1 year of age) who have increased risk of developing tuberculosis. It is rarely given above the age of 16, and never administered above the age of 35 as vaccinations are effective only when administered in early stages of life.

BCG Vaccine Market, by Demographics, 2016 (%)

Get more information on this report : Request Sample Pages

Snapshot of Kenya BCG Vaccine Market

BCG vaccination is part of the immunization schedule of the Kenya Expanded Program on Immunization (KEPI). Therefore, the vaccine is administered to all the children born in Kenyan hospitals. The vaccine is administered as an injection (single dose) on the left forearm of infants immediately after birth. Moreover, in this region, BCG vaccine is generally given along with polio and Hepatitis B vaccines to infants after birth.

Kenya BCG Vaccine Market, 2016-2023 ($Thousand)

Get more information on this report : Request Sample Pages

The list of key players profiled in this report include Merck & Co., Inc., Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group (a subsidiary of China National Pharmaceutical Group Corporation), Serum Institute of India Pvt. Ltd., InterVax Ltd., GreenSignal Bio Pharma Limited (GSBPL), and Statens Serum Institut.

Key Benefits :

The study provides an in-depth analysis of the market with current trends and future estimations from 2016 to 2023 to elucidate the imminent investment pockets.
Comprehensive analysis of factors that drive and restrict the market growth is provided.
Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale are provided.
Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

BCG Vaccine Market Key Segments:

By Demographics

Pediatrics (0-18 years)
Adults (19-35 years)

By Country

India
China
Bangladesh
Pakistan
Indonesia
Japan
Brazil
Mexico
South Africa
Kenya
Thailand
Argentina
Colombia
Chile
Singapore
Rest of the world

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.1.1. Secondary research
1.1.2. Primary research
1.1.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.2.2.1. Competitive intelligence of companies and their strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS

3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.4.4. Impact analysis

3.5. CLINICAL TRIALS

Chapter: 4 GLOBAL BCG VACCINE MARKET, BY DEMOGRAPHICS

4.1. OVERVIEW

4.1.1. Key market trends
4.1.2. Growth factors and opportunities
4.1.3. Market size and forecast

4.2. PEDIATRICS (AGE 0-18 YEARS)

4.2.1. Market size and forecast

4.3. ADULTS (AGE 19-35 YEARS)

4.3.1. Market size and forecast

Chapter: 5 BCG VACCINE MARKET, BY COUNTRY

5.1. OVERVIEW

5.1.1. Key market trends
5.1.2. Growth factors and opportunities
5.1.3. Market size and forecast

5.2. INDIA

5.2.1. Market size and forecast

5.3. CHINA

5.3.1. Market size and forecast

5.4. BANGLADESH

5.4.1. Market size and forecast

5.5. PAKISTAN

5.5.1. Market size and forecast

5.6. INDONESIA

5.6.1. Market size and forecast

5.7. JAPAN

5.7.1. Market size and forecast

5.8. BRAZIL

5.8.1. Market size and forecast

5.9. MEXICO

5.9.1. Market size and forecast

5.10. SOUTH AFRICA

5.10.1. Market size and forecast

5.11. KENYA

5.11.1. Market size and forecast

5.12. THAILAND

5.12.1. Market size and forecast

5.13. ARGENTINA

5.13.1. Market size and forecast

5.14. COLOMBIA

5.14.1. Market size and forecast

5.15. CHILE

5.15.1. Market size and forecast

5.16. SINGAPORE

5.16.1. Market size and forecast

5.17. REST OF THE WORLD

5.17.1. Market size and forecast

Chapter: 6 COMPANY PROFILES

6.1. CHINA NATIONAL BIOTEC GROUP (A SUBSIDIARY OF CHINA NATIONAL PHARMACEUTICAL GROUP CORPORATION)

6.1.1. Company overview
6.1.2. Operating business segments
6.1.3. Business performance
6.1.4. Key strategic moves and developments

6.2. GREENSIGNAL BIO PHARMA LIMITED

6.2.1. Company overview
6.2.2. Operating business segments
6.2.3. Business performance
6.2.4. Key strategic moves and developments

6.3. INTERVAX LTD.

6.3.1. Company overview
6.3.2. Operating business segments
6.3.3. Business performance
6.3.4. Key strategic moves and developments

6.4. JAPAN BCG LABORATORY

6.4.1. Company overview
6.4.2. Operating business segments
6.4.3. Business performance
6.4.4. Key strategic moves and developments

6.5. MERCK & CO., INC.

6.5.1. Company overview
6.5.2. Operating business segments
6.5.3. Business performance
6.5.4. Key strategic moves and developments

6.6. SANOFI PASTEUR

6.6.1. Company overview
6.6.2. Operating business segments
6.6.3. Business performance
6.6.4. Key strategic moves and developments

6.7. SERUM INSTITUTE OF INDIA PVT. LTD.

6.7.1. Company overview
6.7.2. Operating business segments
6.7.3. Business performance
6.7.4. Key strategic moves and developments

6.8. STATENS SERUM INSTITUT

6.8.1. Company overview
6.8.2. Operating business segments
6.8.3. Business performance
6.8.4. Key strategic moves and developments

LIST OF TABLES

TABLE 1. GLOBAL BCG VACCINE MARKET, BY DEMOGRAPHICS, 2016-2023 ($MILLION)
TABLE 2. PEDIATRIC BCG VACCINE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 3. ADULT BCG VACCINE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 4. BCG VACCINE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 5. INDIA BCG VACCINE MARKET, BY DEMOGRAPHICS, 2016-2023 ($MILLION)
TABLE 6. CHINA BCG VACCINE MARKET, BY DEMOGRAPHICS, 2016-2023 ($MILLION)
TABLE 7. BANGLADESH BCG VACCINE MARKET, BY DEMOGRAPHICS, 2016-2023 ($MILLION)
TABLE 8. PAKISPAN BCG VACCINE MARKET, BY DEMOGRAPHICS, 2016-2023 ($MILLION)
TABLE 9. INDONESIA BCG VACCINE MARKET, BY DEMOGRAPHICS, 2016-2023 ($MILLION)
TABLE 10. JAPAN BCG VACCINE MARKET, BY DEMOGRAPHICS, 2016-2023 ($MILLION)
TABLE 11. BRAZIL BCG VACCINE MARKET, BY DEMOGRAPHICS, 2016-2023 ($MILLION)
TABLE 12. MEXICO BCG VACCINE MARKET, BY DEMOGRAPHICS, 2016-2023 ($MILLION)
TABLE 13. SOUTH AFRICA BCG VACCINE MARKET, BY DEMOGRAPHICS, 2016-2023 ($MILLION)
TABLE 14. KENYA BCG VACCINE MARKET, BY DEMOGRAPHICS, 2016-2023 ($MILLION)
TABLE 15. THAILAND BCG VACCINE MARKET, BY DEMOGRAPHICS, 2016-2023 ($MILLION)
TABLE 16. ARGENTINA BCG VACCINE MARKET, BY DEMOGRAPHICS, 2016-2023 ($MILLION)
TABLE 17. COLOMBIA BCG VACCINE MARKET, BY DEMOGRAPHICS, 2016-2023 ($MILLION)
TABLE 18. CHILE BCG VACCINE MARKET, BY DEMOGRAPHICS, 2016-2023 ($MILLION)
TABLE 19. SINGAPORE BCG VACCINE MARKET, BY DEMOGRAPHICS, 2016-2023 ($MILLION)
TABLE 20. REST OF THE WORLD BCG VACCINE MARKET, BY DEMOGRAPHICS, 2016-2023 ($MILLION)
TABLE 21. CHINA NATIONAL BIOTEC: COMPANY SNAPSHOT
TABLE 22. GSBPL: COMPANY SNAPSHOT
TABLE 23. INTERVAX: COMPANY SNAPSHOT
TABLE 24. JAPAN BCG LABORATORY: COMPANY SNAPSHOT
TABLE 25. MERCK: COMPANY SNAPSHOT
TABLE 26. SANOFI: COMPANY SNAPSHOT
TABLE 27. SERUM INSTITUTE OF INDIA: COMPANY SNAPSHOT
TABLE 28. STATENS SERUM INSTITUT: COMPANY SNAPSHOT

LIST OF FIGURES

FIGURE 1. ENT & BRONCHOSCOPY DEVICES MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 6. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIGURE 7. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 8. MARKET SHARE ANALYSIS, BCG VACCINE MARKET, 2016 (%)
FIGURE 9. IMPACT ANALYSIS: BCG VACCINE MARKET
FIGURE 10. CLINICAL TRIALS CONDUCTED IN BCG VACCINE MARKET

The global BCG vaccine market is expected to increase in the near future, owing to high prevalence of tuberculosis, increase in research in the field of vaccines, and rise in government initiatives and focus on immunization programs globally. BCG vaccines have gained popularity in developing countries, as it is the only vaccine available for TB, and is on the World Health Organization’s (WHO) list of essential medicines. However, there can be adverse effects of BCG vaccination in few patients, which restrain the market growth. Furthermore, global shortage of BCG vaccine is also expected to restrict the market growth. India is expected to dominate the global BCG vaccine market in the near future, followed by China.

Shopping Cart is Empty..

Your Shopping Cart Is Empty

BCG Vaccine Market by Demographics [Pediatrics (0-18 Years) and Adults (19-35 Years)] - Global Opportunity Analysis and Industry Forecast, 2017-2023

BCG Vaccine Market Overview:

BCG Vaccine Market Key Segments:

By Demographics

By Country

PURCHASE OPTIONS

Reach out to us

Request Sample

Request Customization

Request sample

Purchase Full Report of
BCG Vaccine Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

Why Allied Market Research

Infallible Methodology

Analyst Support

Customization

TARGETED MARKET VIEW

Featured Reports

Featured Readings

Get Fresh content delivered

About

Contact Us

Find Help

Get notification about our new releases

Our Products & Services

CONNECT WITH US

Press Media

We Accept

BCG Vaccine Market by Demographics [Pediatrics (0-18 Years) and Adults (19-35 Years)] - Global Opportunity Analysis and Industry Forecast, 2017-2023

BCG Vaccine Market Overview:

BCG Vaccine Market Key Segments:

By Demographics

By Country

PURCHASE OPTIONS

Reach out to us

Request Sample

Request Customization

Request sample

Purchase Full Report of BCG Vaccine Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

Why Allied Market Research

Infallible Methodology

Analyst Support

Customization

TARGETED MARKET VIEW

Featured Reports

Featured Readings

Get Fresh content delivered

Purchase Full Report of
BCG Vaccine Market- Global Opportunity Analysis and Industry Forecast, 2017-2023